Knowledge Ecology International
Attending and mending the knowledge ecosystem
KEI letter to Roche requesting voluntary license to patents on risdiplam, a treatment for Spinal Muscular Atrophy (SMA)»Knowledge Ecology International
Menu Close
  • About
  • Areas of work
  • Coronavirus
  • Xtandi
  • Listserves
  • Videos
  • Publications
  • Databases
  • Donate

KEI letter to Roche requesting voluntary license to patents on risdiplam, a treatment for Spinal Muscular Atrophy (SMA)

Posted on July 8, 2022 by James Love

This is a letter to Roche requesting a voluntary license to the patents on risdiplam, a treatment for Spinal Muscular Atrophy (SMA).

KEI-Risdiplan-patent-license-request-8july2022

Access to Medicine risdiplam, Roche, SMA, SMA Foundation

Post navigation

Human Rights Council heats up during informal talks on inequality, international solidarity, and intellectual property
WIPO General Assembly 2022: General statement of Knowledge Ecology International

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

Categories

  • [Test] Post
  • About
  • Access to Knowledge
  • Access to Medicine
  • Competition
  • Delinkage
  • Economics
  • Events
  • Evidence
  • Government Funded research
  • influence
  • Intellectual Property Rights
  • Legislation
  • Litigation
  • Lobbying
  • Marketing
  • Meetings
  • Negotiations
  • Nuclear Proliferation
  • Orphan Drugs
  • Presentations
  • Privacy
  • Public Goods
  • Research and Development
  • Timelines
  • Trade
  • Transparency
  • WHO
  • WIPO
  • WTO
Knowledge Ecology International»Blogs>>KEI letter to Roche requesting voluntary license to patents on risdiplam, a treatment for Spinal Muscular Atrophy (SMA)
© 2022 Knowledge Ecology International. All rights reserved.
Hiero by aThemes